Loading chat...
RI H7537
Bill
Status
2/6/2026
Primary Sponsor
Karen Alzate
Click for details
AI Summary
-
Requires all individual and group health insurance policies delivered, issued, or renewed on or after January 1, 2027 to cover FDA-approved scalp cooling systems for cancer patients undergoing chemotherapy
-
Scalp cooling systems are defined as medical devices designed to cool the scalp to prevent or reduce chemotherapy-induced hair loss (alopecia) before, during, and/or after treatment
-
Applies to accident and sickness insurance policies, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations
-
Exempts limited benefit policies including hospital confinement indemnity, disability income, accident only, long-term care, Medicare supplement, and specified disease indemnity coverage
-
Takes effect upon passage
Legislative Description
Mandates insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.
Insurance
Last Action
Committee recommended measure be held for further study
3/3/2026